Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs MINISO Group Holding Ltd (MNSO) Price & Performance

Hims and Hers Health IncTrade
MINISO Group Holding LtdTrade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs MINISO Group Holding Ltd — how do they compare? Hims and Hers Health Inc trades at $29.5 (market cap $7.12B), while MINISO Group Holding Ltd trades at $11.85 (market cap $3.62B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and MINISO Group Holding Ltd pays a 5.53% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

HIMSMNSO
Market Cap
$7.12B$3.62B
Sector
HealthTechnology
52-Week High
$62.76$26.63
52-Week Low
$14.52$11.30
Enterprise Value
$7.82B$4.29B
Dividend Yield
5.53%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

HIMS stock declined 7.11% to $29.51 following mixed Q2 2026 results, where revenue beat expectations but the company posted a wider-than-expected loss. The technical picture is neutral with bearish moving average signals, while fundamentals show strong revenue growth but deteriorating margins. Recent news highlights margin pressure from GLP-1 drug investments and an FTC investigation, creating investor uncertainty despite raised revenue guidance.

The outlook remains cautious as strong subscriber growth and AI initiatives are offset by profitability challenges and regulatory scrutiny. Investment opportunity exists in the company's expanding global footprint and raised revenue targets, but risks include margin compression, negative cash flow trends, and ongoing legal investigations that could pressure the stock near-term.

MINISO Group Holding Ltd

MNSO trades at $11.9, down 4.95% in the last session, with a neutral technical signal and bearish moving averages. Recent earnings showed a Q1 2026 beat but prior misses, while fundamentals include a P/E of 12.16 and net margin of 8.98%. The company announced a $2 billion share repurchase in June 2026, supporting sentiment amid mixed performance.

Outlook is cautiously optimistic with 75% analyst buy ratings, but risks include margin pressure from SG&A costs and competitive retail markets. The stock offers value if earnings growth sustains, though volatility from recent declines warrants monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS

About MINISO Group Holding Ltd

MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.

Read more on MNSO